Literature DB >> 8384365

Preparation of heptakis(2,6-di-O-ethyl)-beta-cyclodextrin and its nuclear magnetic resonance spectroscopic characterization.

F Hirayama1, M Kurihara, Y Horiuchi, T Utsuki, K Uekama, M Yamasaki.   

Abstract

Heptakis(2,6-di-O-ethyl)-beta-cyclodextrin (DE-beta-CyD) was prepared and its 1H and 13C nuclear magnetic resonance (NMR) signals in DMSO-d6 were unequivocally assigned by two-dimensional COSY and ROESY. The results on 1H coupling constants indicated that all ethylated glucose units are in a 4C1 chair conformation. The average spin-lattice relaxation times (T1) of ring carbons of DE-beta-CyD were only slightly shorter, and their standard deviations from the mean T1 value were larger, than those of beta-cyclodextrin (beta-CyD) and heptakis(2,6-di-O-methyl)-beta-cyclodextrin (DM-beta-CyD), suggesting the presence of slightly irregular internal motion in the ethylated glucose units. The temperature dependence of chemical shift of DE-beta-CyD in DMSO-d6 suggested that the C3 hydroxyl protons may participate as proton donor in the intramolecular hydrogen bond to the C2 ethoxyl groups of neighboring glucose, and the intramolecular hydrogen bond of DE- and DM-beta-CyDs is much stronger than that of beta-CyD, suggesting the stable macrocyclic ring structure of DE-beta-CyD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384365     DOI: 10.1023/a:1018926508695

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Ethylated beta-cyclodextrins as hydrophobic drug carriers: sustained release of diltiazem in the rat.

Authors:  K Uekama; N Hirashima; Y Horiuchi; F Hirayama; T Ijitsu; M Ueno
Journal:  J Pharm Sci       Date:  1987-08       Impact factor: 3.534

2.  Carbon-13 nuclear magnetic resonance studies of the conformations of cyclic dipeptides.

Authors:  R Deslauriers; Z Grzonka; K Schaumburg; T Shiba; R Walter
Journal:  J Am Chem Soc       Date:  1975-09-03       Impact factor: 15.419

3.  Sustained release of buserelin acetate, a luteinizing hormone-releasing hormone agonist, from an injectable oily preparation utilizing ethylated beta-cyclodextrin.

Authors:  K Uekama; H Arima; T Irie; K Matsubara; T Kuriki
Journal:  J Pharm Pharmacol       Date:  1989-12       Impact factor: 3.765

4.  Artificial enzymes.

Authors:  R Breslow
Journal:  Science       Date:  1982-11-05       Impact factor: 47.728

Review 5.  Current aspects of practical two-dimensional (2D) nuclear magnetic resonance (NMR) spectroscopy: applications to structure elucidation.

Authors:  R W Kriwacki; T P Pitner
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

6.  Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.

Authors:  F Hirayama; N Hirashima; K Abe; K Uekama; T Ijitsu; M Ueno
Journal:  J Pharm Sci       Date:  1988-03       Impact factor: 3.534

Review 7.  Cyclodextrins in drug carrier systems.

Authors:  K Uekama; M Otagiri
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

8.  Slow-release characteristics of diltiazem from ethylated beta-cyclodextrin complexes.

Authors:  Y Horiuchi; F Hirayama; K Uekama
Journal:  J Pharm Sci       Date:  1990-02       Impact factor: 3.534

  8 in total
  2 in total

Review 1.  Carbohydrate-Based Host-Guest Complexation of Hydrophobic Antibiotics for the Enhancement of Antibacterial Activity.

Authors:  Daham Jeong; Sang-Woo Joo; Vijay Vilas Shinde; Eunae Cho; Seunho Jung
Journal:  Molecules       Date:  2017-08-08       Impact factor: 4.411

2.  In Search of the Most Stable Molecular Configuration of Heptakis(2,6-O-dimethyl)-β-cyclodextrin and Its Complex with Mianserin: A Comparison of the B3LYP-GD2 and M062X-GD3 Results.

Authors:  Anna Ignaczak; Łukasz Orszański
Journal:  J Phys Chem B       Date:  2021-11-24       Impact factor: 2.991

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.